Unlike traditional small-molecule drugs, which interact with proteins, RNA therapies modulate gene expression directly, enabling interventions at the root of disease.
The future promises tunable therapies with polarity adjustable by light, magnetic fields, or bioorthogonal triggers.
Mirror-image molecules, known as enantiomers, are no longer mere curiosities but powerful tools reshaping drug discovery.
One of the most pressing challenges in anti-diabetic therapy is reducing the unpleasant and often debilitating gastrointestinal side effects that accompany α-amylase inhibition.
Simulating with precision and formulating with insight, the future of pharmacology becomes not just predictive but programmable, one cell at a time.
In manufacturing, minimizing granulation lines, drying tunnels, and multiple milling stages reduces equipment costs, process footprint, and energy consumption.
tagFinder exemplifies the convergence of computational innovation and chemical biology, offering a robust framework to navigate the complexities of DNA-encoded science
Microphysiological systems provide human-relevant data to address pharmacology challenges and streamline approvals for complex cases like rare diseases.
Molecular dynamics simulations have been instrumental in exploring molecular interactions, providing atomic-level understanding of phenomena such as protein folding, ligand binding, and enzymatic catalysis.
This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Cookie settings